Precigen, Inc. (PGEN) is the 37th largest of 174 Gene and Cell Therapy companies by market capitalisation, at 2.55 Bn, behind uniQure N.V. at 2.92 Bn. The table below compares all 174 on 8 financial metrics.
| # | Ticker | Company | match | industry_code | industry_group | industry_group_code | Market Capitalization | P/E | P/S | Enterprise Value |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | KRYS | Krystal Biotech, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 10.54 Bn | 43.66 | 23.93 | 9.70 Bn |
| 2 | CRSP | CRISPR Therapeutics AG | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 5.39 Bn | -11.13 | 402.14 | 5.39 Bn |
| 3 | LEGN | Legend Biotech Corp | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 3.98 Bn | -188.81 | 3.13 | 3.01 Bn |
| 4 | IOVA | Iovance Biotherapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 3.91 Bn | -18.70 | 12.03 | 3.61 Bn |
| 5 | BEAM | Beam Therapeutics Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 3.11 Bn | -36.43 | 19.94 | 3.11 Bn |
| 6 | QURE | uniQure N.V. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 2.92 Bn | -14.84 | 156.29 | 2.92 Bn |
| 7 | PGEN | Precigen, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 2.55 Bn | -7.57 | 29.75 | 2.55 Bn |
| 8 | SRPT | Sarepta Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 2.34 Bn | -17.10 | 1.19 | 1.55 Bn |
| 9 | MESO | Mesoblast Ltd | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 2.24 Bn | -38.60 | 18.46 | 2.14 Bn |
| 10 | TSHA | Taysha Gene Therapies, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 2.05 Bn | -13.73 | 374.43 | 2.05 Bn |
| 11 | VCEL | Vericel Corp | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 2.04 Bn | 81.36 | 6.66 | 1.88 Bn |
| 12 | NTLA | Intellia Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 1.72 Bn | -4.30 | 28.84 | 1.72 Bn |
| 13 | SLDB | Solid Biosciences Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 1.49 Bn | -7.28 | — | 1.49 Bn |
| 14 | MGTX | MeiraGTx Holdings plc | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 1.26 Bn | 7.64 | 3.14 | 1.12 Bn |
| 15 | IMTX | Immatics N.V. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 1.15 Bn | -4.77 | 23.66 | 0.69 Bn |
| 16 | SANA | Sana Biotechnology, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 1.15 Bn | -5.35 | — | 1.15 Bn |
| 17 | FDMT | 4D Molecular Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 1.05 Bn | -5.86 | 11.42 | 0.69 Bn |
| 18 | CADL | Candel Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.96 Bn | -14.57 | — | 0.96 Bn |
| 19 | IMMX | Immix Biopharma, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.89 Bn | -28.22 | — | 0.89 Bn |
| 20 | NGNE | Neurogene Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.88 Bn | -7.86 | — | 0.88 Bn |
| 21 | PRME | Prime Medicine, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.66 Bn | -3.49 | 161.21 | 0.66 Bn |
| 22 | ALLO | Allogene Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.65 Bn | -3.93 | 140.36 | 0.65 Bn |
| 23 | AUTL | Autolus Therapeutics plc | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.60 Bn | -2.32 | 5.32 | 0.39 Bn |
| 24 | BNTC | Benitec Biopharma Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.58 Bn | -12.50 | — | 0.58 Bn |
| 25 | CAPR | Capricor Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.55 Bn | -4.32 | — | 0.55 Bn |
| 26 | CABA | Cabaletta Bio, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.52 Bn | -2.85 | — | 0.52 Bn |
| 27 | KYTX | Kyverna Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.50 Bn | -3.31 | — | 0.50 Bn |
| 28 | RGNX | REGENXBIO Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.47 Bn | -2.67 | 2.50 | 0.37 Bn |
| 29 | OCGN | Ocugen, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.46 Bn | -5.57 | 99.46 | 0.36 Bn |
| 30 | ARTV | Artiva Biotherapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.44 Bn | -4.88 | — | 0.44 Bn |
| 31 | IRD | Opus Genetics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.44 Bn | -4.53 | 44.69 | 0.35 Bn |
| 32 | IPSC | Century Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.44 Bn | -4.00 | — | 0.18 Bn |
| 33 | RCKT | Rocket Pharmaceuticals, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.43 Bn | -25.02 | — | 0.43 Bn |
| 34 | LXEO | Lexeo Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.42 Bn | -4.85 | — | 0.42 Bn |
| 35 | PROK | Prokidney Corp. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.38 Bn | -2.87 | 468.68 | 0.38 Bn |
| 36 | ABEO | Abeona Therapeutics Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.34 Bn | -3.14 | 13.29 | 0.19 Bn |
| 37 | LYEL | Lyell Immunopharma, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.34 Bn | -1.36 | 12,408.88 | 0.34 Bn |
| 38 | CLLS | Cellectis S.A. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.33 Bn | -9.83 | 5.53 | 0.16 Bn |
| 39 | FATE | Fate Therapeutics Inc | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.30 Bn | -2.38 | 45.91 | 0.30 Bn |
| 40 | EDIT | Editas Medicine, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.28 Bn | — | — | 0.14 Bn |
| 41 | NWBO | Northwest Biotherapeutics Inc | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.28 Bn | -7.18 | 128.49 | 0.28 Bn |
| 42 | LCTX | Lineage Cell Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.27 Bn | -11.91 | 20.88 | 0.22 Bn |
| 43 | RNAC | Cartesian Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.27 Bn | -2.50 | 183.55 | 0.27 Bn |
| 44 | TARA | Protara Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.24 Bn | -3.43 | — | 0.24 Bn |
| 45 | NKTX | Nkarta, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.22 Bn | -1.52 | — | 0.22 Bn |
| 46 | VYGR | Voyager Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.21 Bn | -2.55 | 6.09 | 0.09 Bn |
| 47 | DTIL | Precision Biosciences Inc | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.19 Bn | -5.69 | 4.29 | 0.11 Bn |
| 48 | CRBU | Caribou Biosciences, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.16 Bn | -1.45 | 15.85 | 0.05 Bn |
| 49 | TNYA | Tenaya Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.15 Bn | -1.45 | 111.69 | 0.15 Bn |
| 50 | ATRA | Atara Biotherapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.15 Bn | -6.31 | 23.95 | 0.13 Bn |
| 51 | ZSQR | Z Squared Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.15 Bn | -7.69 | 53.02 | 0.13 Bn |
| 52 | HUMA | Humacyte, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.14 Bn | -1.18 | 66.50 | 0.14 Bn |
| 53 | ENGN | enGene Therapeutics Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.13 Bn | -1.00 | — | 0.13 Bn |
| 54 | ACET | Adicet Bio, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.10 Bn | -1.05 | — | -0.01 Bn |
| 55 | ANIX | Anixa Biosciences Inc | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.10 Bn | -9.94 | — | 0.10 Bn |
| 56 | INMB | Inmune Bio, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.06 Bn | -3.12 | — | 0.04 Bn |
| 57 | INKT | MiNK Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.06 Bn | -5.02 | — | 0.06 Bn |
| 58 | APTN | Adaptin Bio, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.06 Bn | -10.22 | — | 0.06 Bn |
| 59 | TCRX | TScan Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -0.43 | 7.12 | 0.05 Bn |
| 60 | SGMOQ | Sangamo Therapeutics, Inc | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -0.37 | 1.14 | 0.02 Bn |
| 61 | CELU | Celularity Inc | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -0.48 | 1.65 | 0.04 Bn |
| 62 | MGX | Metagenomi Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -0.47 | 2.02 | 0.04 Bn |
| 63 | ESLA | Estrella Immunopharma, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -3.79 | — | 0.03 Bn |
| 64 | TVGN | Tevogen Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -1.21 | — | 0.03 Bn |
| 65 | MRKR | Marker Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -2.29 | — | 0.01 Bn |
| 66 | INAB | In8Bio, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -1.28 | — | 0.02 Bn |
| 67 | LGVN | Longeveron Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.90 | 17.97 | 0.01 Bn |
| 68 | GNTA | Genenta Science S.p.A. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -3.83 | — | -0.01 Bn |
| 69 | PASG | Passage BIO, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.39 | — | 0.02 Bn |
| 70 | PLUR | Pluri Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | 0.00 | 10.00 | 0.00 Bn |
| 71 | ADIA | Adia Nutrition, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -75.51 | 69.62 | 0.01 Bn |
| 72 | FBLG | FibroBiologics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.67 | — | 0.01 Bn |
| 73 | SNTI | Senti Biosciences Holdings, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.16 | 607.51 | 0.01 Bn |
| 74 | GDTC | CytoMed Therapeutics Ltd | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -3.36 | 41.92 | 0.01 Bn |
| 75 | ZEOX | Zeo ScientifiX, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -2.21 | 1.34 | 0.01 Bn |
| 76 | LNAI | Lunai Bioworks Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.01 Bn | -0.05 | 86.15 | 0.00 Bn |
| 77 | TPST | Tempest Therapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.28 | — | 0.00 Bn |
| 78 | PMCB | PharmaCyte Biotech, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.18 | — | 0.00 Bn |
| 79 | MBIO | Mustang Bio, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -1.21 | — | 0.00 Bn |
| 80 | ISCO | International Stem Cell CORP | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -9.66 | 0.32 | 0.00 Bn |
| 81 | CLDI | Calidi Biotherapeutics, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.08 | — | 0.00 Bn |
| 82 | GNPX | Genprex, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | — | — | -0.01 Bn |
| 83 | CELZ | Creative Medical Technology Holdings, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.21 | 515.15 | 0.00 Bn |
| 84 | RMTG | Regenerative Medical Technology Group Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.11 | 0.12 | 0.00 Bn |
| 85 | BRTX | BioRestorative Therapies, Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | 0.00 | 0.18 | 0.00 Bn |
| 86 | ERNAW | Ernexa Therapeutics Inc. | primary | H-03 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | 0.00 | — | 0.00 Bn |
| 87 | JNJ | Johnson & Johnson | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 663.00 Bn | 31.52 | 6.77 | 642.24 Bn |
| 88 | TMO | Thermo Fisher Scientific Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 227.37 Bn | 32.30 | 4.91 | 223.31 Bn |
| 89 | GILD | Gilead Sciences, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 187.36 Bn | -64.72 | 6.15 | 184.18 Bn |
| 90 | DHR | Danaher Corp /De/ | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 146.15 Bn | 36.63 | 5.82 | 141.80 Bn |
| 91 | VRTX | Vertex Pharmaceuticals Inc / Ma | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 138.87 Bn | 31.52 | 11.03 | 131.01 Bn |
| 92 | BDX | Becton Dickinson & Co | secondary | H-07 | Medical Devices and Diagnostics | HG-02 | 50.82 Bn | 53.95 | 2.19 | 49.96 Bn |
| 93 | A | Agilent Technologies, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 42.59 Bn | 29.58 | 5.78 | 40.84 Bn |
| 94 | IDXX | Idexx Laboratories Inc /De | secondary | H-05 | Pharmaceuticals and Biotechnology | HG-01 | 42.31 Bn | 37.13 | 9.29 | 42.11 Bn |
| 95 | ILMN | Illumina, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 32.96 Bn | 39.96 | 7.34 | 31.80 Bn |
| 96 | IR | Ingersoll Rand Inc. | secondary | I-10 | Machinery | IG-02 | 29.73 Bn | 30.78 | 3.74 | 28.56 Bn |
| 97 | INSM | INSMED Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 27.41 Bn | -31.31 | 24.09 | 26.25 Bn |
| 98 | MTD | Mettler Toledo International Inc/ | secondary | I-04 | Machinery | IG-02 | 27.29 Bn | 30.14 | 6.60 | 27.24 Bn |
| 99 | ROIV | Roivant Sciences Ltd. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 25.22 Bn | -16.99 | 2,309.22 | 25.22 Bn |
| 100 | STE | STERIS plc | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 21.95 Bn | 27.16 | 3.64 | 21.47 Bn |
| 101 | UTHR | UNITED THERAPEUTICS Corp | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 20.84 Bn | 15.90 | 6.61 | 18.18 Bn |
| 102 | NBIX | Neurocrine Biosciences Inc | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 15.71 Bn | 22.27 | 4.66 | 15.32 Bn |
| 103 | RVTY | Revvity, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 14.57 Bn | 61.35 | 5.01 | 13.55 Bn |
| 104 | CRL | Charles River Laboratories International, Inc. | secondary | H-11 | Pharma Services | HG-03 | 13.88 Bn | -58.41 | 3.47 | 13.69 Bn |
| 105 | BMRN | Biomarin Pharmaceutical Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 12.85 Bn | 176.11 | 3.77 | 11.98 Bn |
| 106 | TECH | BIO-TECHNE Corp | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 11.30 Bn | 62.11 | 9.30 | 11.03 Bn |
| 107 | DCI | DONALDSON Co INC | secondary | I-04 | Machinery | IG-02 | 10.55 Bn | 24.04 | 2.77 | 10.35 Bn |
| 108 | BIO | Bio-Rad Laboratories, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 10.32 Bn | 46.41 | 3.99 | 8.70 Bn |
| 109 | RGEN | Repligen Corp | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 9.45 Bn | 153.03 | 12.04 | 8.44 Bn |
| 110 | BRKR | Bruker Corp | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 9.01 Bn | -84.29 | 2.57 | 9.01 Bn |
| 111 | IBRX | ImmunityBio, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 8.48 Bn | -8.54 | 51.14 | 8.12 Bn |
| 112 | TXG | 10x Genomics, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 8.05 Bn | -107.14 | 13.05 | 7.50 Bn |
| 113 | TGTX | Tg Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 7.97 Bn | 18.05 | 9.97 | 7.29 Bn |
| 114 | TWST | Twist Bioscience Corp | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 7.77 Bn | -56.83 | 18.00 | 7.60 Bn |
| 115 | GRFS | Grifols SA | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 5.33 Bn | 20.99 | 0.32 | 4.17 Bn |
| 116 | GRAL | GRAIL, Inc. | secondary | H-17 | Healthcare Providers | HG-04 | 3.44 Bn | -8.78 | 21.88 | 2.58 Bn |
| 117 | NKTR | Nektar Therapeutics | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 2.44 Bn | -20.53 | 44.69 | 1.76 Bn |
| 118 | LKFT | Lakefront Biotherapeutics NV | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.89 Bn | 0.01 | 1.63 | 1.89 Bn |
| 119 | BLFS | Biolife Solutions Inc | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 1.72 Bn | 29.76 | 16.77 | 1.64 Bn |
| 120 | RARE | Ultragenyx Pharmaceutical Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 1.59 Bn | -3.44 | 2.22 | 1.30 Bn |
| 121 | AZTA | Azenta, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 1.43 Bn | -4.53 | 1.35 | 1.10 Bn |
| 122 | MRVI | Maravai Lifesciences Holdings, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 1.10 Bn | -8.05 | 5.25 | 1.03 Bn |
| 123 | PCRX | Pacira BioSciences, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 1.04 Bn | 71.08 | 1.39 | 0.79 Bn |
| 124 | CYRX | Cryoport, Inc. | secondary | I-22 | Transportation | IG-05 | 0.80 Bn | -17.71 | 4.31 | 0.41 Bn |
| 125 | MLAB | Mesa Laboratories Inc /Co/ | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 0.72 Bn | 205.75 | 2.90 | 0.69 Bn |
| 126 | CTKB | Cytek Biosciences, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 0.60 Bn | -7.48 | 2.92 | 0.53 Bn |
| 127 | OABI | OmniAb, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.56 Bn | -12.73 | 14.65 | 0.51 Bn |
| 128 | NEUP | Neuphoria Therapeutics Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.47 Bn | -19.83 | — | 0.45 Bn |
| 129 | DNA | Ginkgo Bioworks Holdings, Inc. | secondary | H-11 | Pharma Services | HG-03 | 0.43 Bn | -1.47 | 3.83 | 0.34 Bn |
| 130 | PACB | Pacific Biosciences Of California, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 0.41 Bn | -3.11 | 2.56 | 0.17 Bn |
| 131 | MASS | 908 Devices Inc. | secondary | I-02 | Aerospace and Defense | IG-01 | 0.38 Bn | -13.59 | 6.19 | 0.27 Bn |
| 132 | TKNO | Alpha Teknova, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 0.37 Bn | -28.27 | 8.49 | 0.35 Bn |
| 133 | AGEN | Agenus Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.34 Bn | 3.74 | 2.59 | 0.34 Bn |
| 134 | ALEC | Alector, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.28 Bn | -3.15 | 19.90 | 0.10 Bn |
| 135 | LAB | Standard Biotools Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 0.26 Bn | 3.08 | 3.10 | -0.21 Bn |
| 136 | OSUR | Orasure Technologies Inc | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.26 Bn | — | 2,558.79 | 0.06 Bn |
| 137 | CELG-RI | Bristol Myers Squibb Co | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.25 Bn | 0.03 | 0.01 | -10.82 Bn |
| 138 | QSI | Quantum-Si Inc | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 0.17 Bn | -1.70 | 104.61 | 0.17 Bn |
| 139 | MXCT | Maxcyte, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 0.14 Bn | -3.82 | 4.39 | 0.14 Bn |
| 140 | HURA | TuHURA Biosciences, Inc./NV | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.13 Bn | -4.39 | — | 0.13 Bn |
| 141 | CDXS | Codexis, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 0.13 Bn | -4.28 | 1.69 | 0.08 Bn |
| 142 | QTRX | Quanterix Corp | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 0.13 Bn | -1.02 | 0.82 | 0.03 Bn |
| 143 | NAUT | Nautilus Biotechnology, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 0.11 Bn | -3.58 | 616.04 | 0.11 Bn |
| 144 | GUTS | Fractyl Health, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.11 Bn | -0.87 | — | 0.11 Bn |
| 145 | SEER | Seer, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 0.11 Bn | -2.05 | 7.57 | 0.11 Bn |
| 146 | PLYX | Polaryx Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.10 Bn | -9.65 | — | 0.08 Bn |
| 147 | FBIO | Fortress Biotech, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.09 Bn | 10.33 | 1.25 | -0.11 Bn |
| 148 | RPID | Rapid Micro Biosystems, Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.06 Bn | -1.25 | 1.82 | 0.04 Bn |
| 149 | JANL | Janel Corp | secondary | I-22 | Transportation | IG-05 | 0.06 Bn | 10.85 | 0.25 | 0.03 Bn |
| 150 | IMMP | IMMUTEP Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.05 Bn | -0.44 | 5.23 | 0.00 Bn |
| 151 | SER | Serina Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.04 Bn | -1.50 | 326.44 | 0.02 Bn |
| 152 | HBIO | Harvard Bioscience Inc | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 0.04 Bn | 41.69 | 0.41 | 0.03 Bn |
| 153 | ATNM | Actinium Pharmaceuticals, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | 2.87 | 0.93 | 0.03 Bn |
| 154 | VRXA | Veraxa Biotech AG - Post de-SPAC | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.03 Bn | -0.26 | 755.61 | 0.02 Bn |
| 155 | DYAI | Dyadic International Inc | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -2.57 | 4.82 | 0.02 Bn |
| 156 | CTXR | Citius Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.02 Bn | -0.33 | 2.16 | 0.02 Bn |
| 157 | BNGO | Bionano Genomics, Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 0.01 Bn | -0.53 | 0.47 | 0.00 Bn |
| 158 | ADVB | Advanced Biomed Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.01 Bn | 2.66 | — | 0.01 Bn |
| 159 | SCND | Scientific Industries Inc | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 0.01 Bn | -12.86 | 1.67 | 0.00 Bn |
| 160 | CDIO | Cardio Diagnostics Holdings, Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.01 Bn | -0.84 | 376.85 | 0.00 Bn |
| 161 | CLGN | CollPlant Biotechnologies Ltd | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.69 | 11.76 | 0.00 Bn |
| 162 | HCWB | HCW Biologics Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.11 | 21.21 | 0.00 Bn |
| 163 | CASIF | CASI Pharmaceuticals, Inc. | secondary | H-01 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.02 | 0.12 | 0.00 Bn |
| 164 | GOVX | GeoVax Labs, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.11 | 2.59 | 0.00 Bn |
| 165 | ISPC | iSpecimen Inc. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 0.00 Bn | -0.23 | 4.70 | 0.00 Bn |
| 166 | POAS | PHAOS TECHNOLOGY HOLDINGS (CAYMAN) Ltd | secondary | I-04 | Machinery | IG-02 | 0.00 Bn | -0.42 | 48.74 | 0.00 Bn |
| 167 | BCAB | BioAtla, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.06 | 0.24 | 0.00 Bn |
| 168 | RNAZ | Transcode Therapeutics, Inc. | secondary | H-02 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.04 | — | 0.00 Bn |
| 169 | BJDX | Bluejay Diagnostics, Inc. | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.00 Bn | -0.24 | — | 0.00 Bn |
| 170 | NUMD | Nu-Med Plus, Inc. | secondary | H-06 | Medical Devices and Diagnostics | HG-02 | 0.00 Bn | -100.79 | — | 0.00 Bn |
| 171 | VNRX | Volitionrx Ltd | secondary | H-08 | Medical Devices and Diagnostics | HG-02 | 0.00 Bn | -0.09 | 0.65 | 0.00 Bn |
| 172 | BNBX | Bnb Plus Corp. | secondary | H-10 | Medical Devices and Diagnostics | HG-02 | 0.00 Bn | -0.03 | 0.49 | 0.00 Bn |
| 173 | GRMLW | Greenland Mines Ltd | secondary | H-04 | Pharmaceuticals and Biotechnology | HG-01 | 0.00 Bn | -0.02 | — | -0.01 Bn |
| 174 | NOTVQ | Inotiv, Inc. | secondary | H-11 | Pharma Services | HG-03 | 0.00 Bn | 0.00 | 0.00 | -0.01 Bn |